[
    "{\"step_by_step_thinking\": \"According to Document [0], a multicentre, double-blind, randomised controlled trial called ESCAPE-NA1 assessed the efficacy and safety of nerinetide in human ischaemia-reperfusion that occurs with rapid endovascular thrombectomy in patients who had an acute ischaemic stroke. The trial found that nerinetide did not improve the proportion of patients achieving good clinical outcomes after endovascular thrombectomy compared with patients receiving placebo. Therefore, the answer is B. no.\", \"answer_choice\": \"B\"}"
]